A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro

Journal of Virology

Volumn 74, Issue 7, 2000, Pages 3093-3104

  Chen, Mei Ru ^a   Chang, Shin Jye ^a   Huang, Hsiaowen ^a   Chen, Jen Yang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY ANTIGEN; PROTEIN KINASE; VIRUS ANTIGEN;

ARTICLE; AUTOPHOSPHORYLATION; CATALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSACTIVATION; VIRUS CELL INTERACTION; VIRUS RECOMBINATION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CLONING, MOLECULAR; CYTOPLASM; ENZYME INHIBITORS; ESCHERICHIA COLI; HEPARIN; HERPESVIRUS 4, HUMAN; IMMUNE SERA; KINETICS; MOLECULAR SEQUENCE DATA; OKADAIC ACID; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; THREONINE; VIRAL PROTEINS;

EID: 0034011617     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.7.3093-3104.2000     Document Type: Article

References (55)

1. Ali, M. A., S. S. Prakash, and R. Jariwalla. 1992. Localization of the antigenic sites and intrinsic protein kinase domain within a 300 amino acid segment of the ribonucleotide reductase large subunit from herpes simplex virus type 2. Virology 187:360-367.
2. Beaud, G., A. Sharif, A. Topa-Masse, and D. P. Leader. 1994. Ribosomal protein S2/Sa kinase purified from HeLa cells infected with vaccinia virus corresponds to the B1R protein kinase and phosphorylates in vitro the viral ssDNA-binding protein. J. Gen. Virol. 75:283-293.
3. c-src expression is induced by activation of normal human T lymphocytes. J. Immunol. 154:3678-3685.
4. Cannon, J. S., F. Hamzeh, S. Moore, J. Nicholas, and R. F. Ambinder. 1999. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J. Virol. 73:4786-4793.
5. Chee, M. S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1151-1160.
6. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
7. Chen, M.-R., J.-F. Yang, T.-Y. Hsu, M.-Y. Liu, J.-Y. Chen, and C.-S. Yang. 1996. Use of bacterially expressed GST/EBNA-1 fusion proteins for detection of antibodies in sera from patients with nasopharyngeal carcinoma and healthy donors. Clin. J. Microbiol. Immunol. (Taipei) 29:65-79.
8. Chen, M. R., C. H. Tsai, F. F. Wu, S. H. Kan, C. S. Yang, and J. Y. Chen. 1999. The major immunogenic epitopes of Epstin-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. J. Gen. Virol. 80: 447-455.
9. Chen, M. R., T. Y. Hsu, J. Y. Chen, and C. S. Yang. 1990. Molecular characterization of a cDNA clone encoding the Epstein-Barr virus (EBV) DNase. J. Virol. Methods 29:127-142.
10. Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gill, and M. G. Rasenfeld. 1987. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (London) 328:820-823.
11. Chow, K. C., J. Ma, L. S. Lin, K. H. Chi, S. H. Yen, S. M. Liu, W. T. Liu, W. K. Chen, T. H. Chang, and K. Y. Chen. 1997 Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D. Cancer Epidemiol. Biomarkers Prev. 6:363-368.
12. Chung, T. D., J. P. Wymer, C. C. Smith, M. Kulka, and L. Aurelian. 1989. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J. Virol. 63:3389-3398.
13. Coulter, L. J., H. W. M. Moss, J. Lang, and D. J. McGeoch. 1993. A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J. Gen. Virol. 74:387-395.
14. Cunningham, C., A. J. Davison, A. Dolan, M. C. Frame, D. J. McGeoch, D. M. Meredith, H. W. M. Moss, and A. C. Orr. 1992. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J. Gen. Virol. 73:303-311.
15. Daibata, M., R. E. Humphreys, and T. Sairenji. 1992. Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA. Virology 188:916-920.
16. Daikoku, T., R. Kurachi, T. Tsurumi, and Y. Nishiyama. 1994. Identification of a target protein of US3 protein kinase of herpes simplex virus type 2. J. Gen. Virol. 75:2065-2068.
17. Daikoku, T., Y. Yamashita, T. Tsurumi, and Y. Nishiyama. 1995. The US3 protein kinase of herpes simplex virus type 2 is associated with phosphorylation of the UL12 alkaline nuclease in vitro. Arch. Virol. 140:1637-1644.
18. Dasmahapatra, D. B., E. J. Rozhan, and J. Schwarz. 1987. BD7, a novel cell free expression vector with an efficient translation initiation signal. Nucleic Acids Res. 15:3933.
19. Davison. A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
20. DeWind, N., J. Domen, and A. Berns. 1992. Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. J. Virol. 66:5200-5209.
21. Feighny, R. J., M. P. Farrell, and J. S. Pagano. 1980. Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells. J. Virol. 34:455-463.
22. Glover, C. V., and C. D. Allis. 1991. Enzyme activity dot blot assaying protein kinases. Methods Enzymol. 85:85-90.
23. Hanks, S. K., and T. Hunter. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-596.
24. Heineman, T. C., K. Seidel, and J. I. Cohen. 1996. The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J. Virol. 70:7312-7317.
25. Higgins, D. G., A. J. Bleasby, and R. Fuchs. 1992. CLUSTAL V: improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:189-191.
26. Kawaguchi, Y., T. Matsumura, B. Roizman, and K. Hirai. 1999. Cellular elongation factor 1δ is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses. J. Virol. 73:4456-4460.
27. L13 gene of herpes simplex virus 1. J. Virol. 72:1731-1736.
28. Kiehl, A., and D. I. Dorsky. 1991. Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. Virology 182:330-340.
29. Kolman, J. L., N. Taylor, D. R. Marshak, and G. Miller. 1993. Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation. Proc. Natl. Acad. Sci. USA 90:10115-10119.
30. Langelier, Y., L. Champoux, M. Hamel, C. Guilbault, C. Lamarche, P. Gaudreau, and B. Mawwie. 1998. The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase. J. Biol. Chem. 273:1435-1443.
31. Lawrence, G. L., M. Chee, M. A. Craxton, U. A. Gompels, R. W. Honess, and B. G. Barrell. 1990. Human herpesvirus 6 is closely related to human cytomegalovirus. J. Virol. 64:287-299.
32. Leader, D. P. 1993. Viral protein kinases and protein phosphatases. Pharmacol. Ther. 59:343-389.
33. Li, J. S., B. S. Zhou, G. E. Dutschman, S. P. Grill, R.-S. Tan, and Y.-C. Chen. 1987. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J. Virol. 61:2947-2949.
34. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analog ganciclovir. Nature 358:160-162.
35. Long, M. C., V. Leong, P. A. Scharrer, C. A. Spencer, and S. A. Rice. 1999. ICP22 and UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
36. Luo, J. H., and L. Aurelian. 1992. The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J. Biol. Chem. 267:9645-9653.
37. McGeoch, D. J., and A. J. Davison. 1986. Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res. 14:1765-1777.
38. Moffat, J. F., L. Zerboni, M. H. Sommer, T. C. Heineman, J. I. Cohen, H. Kaneshima, and A. M. Arvin. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 95:11969-11974.
39. Ng, T. I., and C. Grose. 1992. Serine protein kinase associated with varicellazoster virus ORF47. Virology 191:9-18.
40. Ng, T. I., L. Keenan, P. R. Kinchington, and C. Grose. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68:1350-1359.
41. Overton, H. A., D. J. McMillan, L. S. Klavinskis, L. Hope, A. J. Ritchie, and P. Wong-kai-in. 1992. Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion. Virology 190:184-192.
42. Possee, R. D., T. P. Sun, S. C. Howard, M. D. Ayres, M. Hill-Perkins, and K. L. Gearing. 1991. Nucleotide sequence of the Autographa californica nuclaer polyhedrosis 9.4 kbp EcoRI-1 and -R (polyhedrin gene) region. Virology 185:229-241.
43. L13 protein kinase determines the accumulation of a subset of α and γ mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
44. L13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α22. Proc. Natl. Acad. Sci. USA 89:7310-7314.
45. Rempel, R. E., M. K. Anderson, E. Evans, and P. Traktman. 1990. Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J. Virol. 64:574-583.
46. Rempel, R. E., and P. Traktman. 1992. Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J. Virol. 66:4413-4426.
47. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelamn, Y. Chang, and P. S. Moore. 1996 Nucleotide sequence of the Kaposi sarcoma-associated herpes virus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
48. Smith, C. C., T. Peng, M. Kulka, and L. Aurelian. 1998. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J. Virol. 72:9131-9141.
49. Smith, R. F., and T. F. Smith. 1989. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J. Virol. 63:450-455.
50. Soderling, T. R. 1993. Protein kinases and phosphatases: regulation by autoinhibitor domains. Biotechnol. Appl. Biochem. 18:185-200.
51. Stevenson, D., K. L. Colman, and A. J. Davison. 1994. Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J. Gen. Virol. 75:317-326.
52. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. Protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358:162-164.
53. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weigh matrix choice. Nucleic Acids Res. 22:4673-680.
54. Tsai, C.-H., M.-T. Liu, M.-R. Chen, J. Lu, H.-L. Yang, J.-Y. Chen, and C.-S. Yang. 1997. Characterization of monoclonal antibodies to the Zta and DNase proteins of Epstein-Barr virus. J. Biomed. Sci. 4:69-77.
55. Zhang, Q., E. Holley-Guthrie, J.-Q. Ge, D. Dorsky, and S. Kenney. 1997. The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt. Virology 230:22-34.